Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯ÀüÀÚ CYP2C9 ¹× VKORC1 º¯ÀÌ·Î ÀÎÇÑ ¿ÍÆĸ° °ú¹Î¼ºÀ» µ¿¹ÝÇÑ °¡¿Í»çÅ°º´ ȯ¾Æ 1·Ê A child with Kawasaki disease and genetic warfarin sensitivity from CYP2C9 and VKORC1 gene variants

´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸÁö 2020³â 7±Ç 2È£ p.140 ~ 144
ÀÌ¸í¼·, Àº¿µ¹Î,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ¸í¼· ( Lee Myeong-Seob ) 
Yonsei University College of Medicine Department of Pediatircs

Àº¿µ¹Î ( Eun Young-Min ) 
Yonsei University College of Medicine Department of Pediatrics

Abstract


Kawasaki disease (KD) is a common febrile disease in East Asia. Because KD with coronary artery aneurysm (CAA) may predispose to thrombosis, children with KD-associated CAA may need anticoagulation in addition to aspirin. In this report, we describe a 6-year-old girl with KD and CAA who was found to have unexpected warfarin-induced coagulopathy caused by CYP2C9 and VKORC1 genotype variants, which affect warfarin metabolism.

Å°¿öµå

Anticoagulants; Coronary Aneurysm; Cytochrome P-450 Enzyme System; Mucocutaneous Lymph Node Syndrome; Warfarin

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed